MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q4 2019 (Next →)

Filing Date: Feb 14, 2020

Total Value ($000): $282,172 (100.0% shares, 0.0% debt)

Holdings (12)

— Harpoon Therapeutics, Inc. 20.4%

Value ($000) $57,658 Shares 3,898,422 Est. Cost $14.79 Unrealized —

— Epizyme, Inc. 20.3%

Value ($000) $57,356 Shares 2,331,534 Est. Cost $24.60 Unrealized —

— TCR2 Therapeutics, Inc. 17.1%

Value ($000) $48,138 Shares 3,370,982 Est. Cost $14.28 Unrealized —

— G1 Therapeutics, Inc. 13.3%

Value ($000) $37,631 Shares 1,423,794 Est. Cost $26.43 Unrealized —

— ArQule, Inc. 7.7%

Value ($000) $21,840 Shares 1,094,210 Est. Cost $19.96 Unrealized —

— MEI Pharma, Inc. 5.5%

Value ($000) $15,500 Shares 6,250,000 Est. Cost $2.48 Unrealized —

— Deciphera Pharmaceuticals, Inc. 4.8%

Value ($000) $13,417 Shares 215,570 Est. Cost $62.24 Unrealized —

ARGX argenx SE 4.1%

Value ($000) $11,509 Shares 71,700 Est. Cost $160.52 Unrealized —

— YmAbs Therapeutics, Inc. 3.7%

Value ($000) $10,540 Shares 337,291 Est. Cost $31.25 Unrealized —

CTMX CytomX Therapeutics, Inc. 2.5%

Value ($000) $7,109 Shares 855,437 Est. Cost $6.75 Unrealized 0.0%

— Sunesis Pharmaceuticals, Inc. 0.3%

Value ($000) $949 Shares 2,809,912 Est. Cost $0.34 Unrealized —

AUTL Autolus Therapeutics Limited 0.2%

Value ($000) $525 Shares 39,740 Est. Cost $13.21 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Harpoon Therapeutics, Inc.	3,898,422	$57,658	20.4%	$14.79	—	Common	41358P106
—	Epizyme, Inc.	2,331,534	$57,356	20.3%	$24.60	—	Common	29428V104
—	TCR2 Therapeutics, Inc.	3,370,982	$48,138	17.1%	$14.28	—	Common	87808K106
—	G1 Therapeutics, Inc.	1,423,794	$37,631	13.3%	$26.43	—	Common	3621LQ109
—	ArQule, Inc.	1,094,210	$21,840	7.7%	$19.96	—	Common	04269E107
—	MEI Pharma, Inc.	6,250,000	$15,500	5.5%	$2.48	—	Common	552798202
—	Deciphera Pharmaceuticals, Inc.	215,570	$13,417	4.8%	$62.24	—	Common	24344T101
ARGX	argenx SE	71,700	$11,509	4.1%	$160.52	—	Common	04016X101
—	YmAbs Therapeutics, Inc.	337,291	$10,540	3.7%	$31.25	—	Common	984241109
CTMX	CytomX Therapeutics, Inc.	855,437	$7,109	2.5%	$6.75	0.0%	Common	23284F105
—	Sunesis Pharmaceuticals, Inc.	2,809,912	$949	0.3%	$0.34	—	Common	867328700
AUTL	Autolus Therapeutics Limited	39,740	$525	0.2%	$13.21	—	Common	05280R100